Enhancing HIV prevention and reducing alcohol use among people receiving STI care in Malawi: An HIV status neutral approach
Project Number5R34AA030939-02
Contact PI/Project LeaderPARCESEPE, ANGELA Other PIs
Awardee OrganizationUNIV OF NORTH CAROLINA CHAPEL HILL
Description
Abstract Text
PROJECT SUMMARY
HIV continues to be a significant public health problem throughout sub-Saharan Africa, including in Malawi.
Sexually transmitted infection (STI) care settings are underutilized venues to simultaneously reach virally
unsuppressed people with HIV (PWH) and those at high risk of HIV and have the potential to optimize HIV
prevention and treatment outcomes. Hazardous alcohol use is widespread in Malawi and among people
receiving STI care and is a critical barrier to the success of HIV prevention efforts. TrEAT is a brief, highly
effective, culturally appropriate, scalable, evidence-based intervention (EBI) for alcohol reduction. While
culturally appropriate for diverse settings, TrEAT has not been adapted for the shifting HIV care environment
that includes both PWH and people at high risk for HIV. Through preliminary work, our team has demonstrated
that: 1) Hazardous alcohol use is highly prevalent among people receiving STI care in SSA, including Malawi;
2) TrEAT is culturally appropriate, feasibile, acceptable, and effective at reducing alcohol use and improving
viral suppression among PWH across global settings, including in SSA; and 3) Successfully led alcohol
reduction and HIV prevention and treatment effectiveness and implementation studies. The overall goal for this
R34 application is to produce a culturally adapted, scalable HIV ‘status-neutral’ EBI for alcohol reduction and
HIV prevention and treatment optimization to test in an R01 hybrid effectiveness-implementation trial. We will
conduct a 2-arm pilot randomized controlled trial (RCT) comparing TrEAT4All to usual care to assess the
preliminary efficacy and implementation of HIV prevention and treatment within one STI care setting which
serves as an early Pre-exposure Prophylaxis (PrEP) implementation site in Lilongwe, Malawi. Drawing from
our previous manualized interventions, we will develop a 3-session intervention, TrEAT4All, that integrates HIV
prevention and treatment counseling into TrEAT to improve HIV prevention outcomes—PrEP use for those
who are at risk for HIV and viral suppression for PWH. Our specific aims are to 1) Adapt TrEAT, an EBI for
alcohol reduction, to integrate HIV status-neutral counseling (TrEAT4All) for PWH and those at high risk of HIV
who report heavy drinking and are receiving STI care in Malawi; 2) Evaluate short-term efficacy and
implementation of TrEAT4All for optimizing HIV prevention and treatment outcomes (viral suppression among
PWH; PrEP use among those at high risk of HIV) and proportion of heavy drinking days in past 30 days; and 3)
Explore pathways of TrEAT4All responsiveness among intervention participants. Results will have relevance
for integrating alcohol reduction EBIs into real-world STI care settings to optimize HIV prevention and
treatment programs throughout sub-Saharan Africa and other regions where alcohol plays a role in HIV
spread.
Public Health Relevance Statement
PROJECT NARRATIVE
People with sexually transmitted infections (STI) who report hazardous drinking are a priority
population for interventions to improve primary and secondary HIV prevention. We will adapt
and test a brief alcohol reduction intervention to integrate primary and secondary HIV prevention
counseling for people with and at risk of HIV who report hazardous drinking and are receiving
STI care. Our study will provide critical guidance to practitioners, program implementers, and
policymakers on the efficacy and implementation of alcohol reduction interventions for people
receiving STI care in resource-limited settings.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AIDS preventionAdherenceAdultAfrica South of the SaharaAlcohol abuseAlcohol consumptionAlcohol dependenceAlcoholsBehavior TherapyBehavioralBiological MarkersCaringClinicCognitiveCounselingElementsEnrollmentEnvironmentEvidence based interventionFailureGoalsHIVHIV SeronegativityHeavy DrinkingHuman immunodeficiency virus testIncidenceInfectionInterventionInterviewMalawiManualsMethodsModelingMotivationMultiple PartnersNewly DiagnosedOutcomeParticipantPathway interactionsPersonsPolicy MakerPopulation HeterogeneityPopulation InterventionPopulations at RiskPrevalencePrevention programProblem SolvingProfessional counselorProviderPublic HealthRandomizedRandomized, Controlled TrialsReportingResearchResearch InfrastructureResource-limited settingRiskSexually Transmitted DiseasesSiteStructureTestingTreatment EffectivenessTreatment outcomeUnsafe SexViralVirus SheddingWomanWorkalcohol abuse therapyalcohol interventionalcohol preventionalcohol use disorderantiretroviral therapyarmco-infectioneffectiveness studyeffectiveness/implementation trialflexibilityhazardous drinkinghigh riskhigh risk populationimplementation measuresimplementation studyimprovedinnovationintervention participantsmenmotivational enhancement therapyphosphatidylethanolpre-exposure prophylaxisprevention effectivenessprogramsreduced alcohol useresponders and non-respondersskillssuccesstransmission processtreatment as usualtreatment optimizationtreatment programtrial comparinguptake
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
273
DUNS Number
608195277
UEI
D3LHU66KBLD5
Project Start Date
01-July-2023
Project End Date
30-June-2026
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$203,981
Direct Costs
$180,500
Indirect Costs
$23,481
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Alcohol Abuse and Alcoholism
$203,981
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R34AA030939-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R34AA030939-02
Patents
No Patents information available for 5R34AA030939-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R34AA030939-02
Clinical Studies
No Clinical Studies information available for 5R34AA030939-02
News and More
Related News Releases
No news release information available for 5R34AA030939-02
History
No Historical information available for 5R34AA030939-02
Similar Projects
No Similar Projects information available for 5R34AA030939-02